On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...

FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...

Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...

Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...

The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...

The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.

US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...